About all

Castro congitis. Exploring the Complexities of Costochondritis: Understanding the Causes, Symptoms, and Management Strategies

What is costochondritis? Is your chest pain caused by costochondritis? Discover the answers to these questions and more as we delve into the causes, symptoms, and effective management strategies for this often misunderstood condition.

Understanding Costochondritis: The Basics

Costochondritis, also known as Tietze’s syndrome, is a condition characterized by inflammation of the cartilage that connects the ribs to the breastbone (sternum). This inflammation can lead to chest pain, which can be a source of significant discomfort and concern for those affected.

Causes of Costochondritis: Unraveling the Mystery

The exact cause of costochondritis is not always clear, but it is often associated with various factors, including:

  • Injury or trauma to the chest area
  • Repetitive strain or overuse of the chest muscles
  • Certain medical conditions, such as rheumatoid arthritis, fibromyalgia, or osteoarthritis
  • Respiratory infections or illnesses that cause coughing or sneezing

In some cases, the cause of costochondritis may remain unknown, making it a challenging condition to diagnose and manage.

Symptoms of Costochondritis: Recognizing the Signs

The primary symptom of costochondritis is chest pain, which can be characterized by the following:

  • Localized pain or tenderness in the chest, specifically along the breastbone or ribs
  • Increased pain with movement, deep breathing, or coughing
  • Mild to moderate intensity of pain, which can range from a dull ache to a sharp, stabbing sensation
  • Worsening of pain with physical activity or certain body positions

It’s important to note that the pain associated with costochondritis is typically not accompanied by other signs of a heart attack, such as shortness of breath, sweating, or radiating pain down the arm.

Diagnosing Costochondritis: Ruling Out Other Conditions

Diagnosing costochondritis can be challenging, as the symptoms can resemble those of other medical conditions, such as a heart attack or other cardiovascular issues. To make a proper diagnosis, your healthcare provider will likely perform the following steps:

  1. Physical examination: Your provider will carefully examine the chest area, palpating the affected cartilage to assess for tenderness and inflammation.
  2. Medical history: Your provider will ask about your symptoms, any recent injuries or activities, and any underlying medical conditions that may be contributing to the chest pain.
  3. Imaging tests: In some cases, your provider may order X-rays or other imaging tests to rule out other potential causes of your chest pain, such as a fractured rib or other structural abnormalities.

Once other potential causes have been ruled out, your provider may diagnose you with costochondritis based on the characteristic symptoms and physical examination findings.

Managing Costochondritis: Effective Treatment Strategies

The good news is that costochondritis is generally a self-limiting condition, meaning it will often resolve on its own with time and proper management. The main goals of treatment are to alleviate the pain and discomfort and to address any underlying factors that may be contributing to the condition. Some common treatment approaches include:

  • Rest and activity modification: Avoiding activities that exacerbate the pain and allowing the affected area to heal.
  • Over-the-counter pain medications: Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or naproxen can help reduce inflammation and pain.
  • Topical treatments: Applying heat or cold compresses to the affected area can provide relief.
  • Stretching and exercise: Gentle stretching and strengthening exercises may help improve flexibility and reduce the risk of recurrence.
  • Corticosteroid injections: In some cases, your provider may recommend a corticosteroid injection to the affected area to reduce inflammation and pain.

In most cases, the pain associated with costochondritis will gradually improve over the course of a few weeks to a few months with appropriate management. However, if the pain persists or worsens, it’s important to consult with your healthcare provider to ensure that there are no underlying medical conditions that require further evaluation or treatment.

Preventing Costochondritis: Strategies for Reducing Risk

While it’s not always possible to prevent costochondritis, there are some steps you can take to reduce your risk:

  • Maintain good posture and avoid activities that put excessive strain on the chest and rib area.
  • Engage in regular, low-impact exercise to keep the chest and back muscles strong and flexible.
  • Practice stress management techniques, as high levels of stress can contribute to muscle tension and inflammation.
  • Avoid sudden or intense physical activities that may lead to overuse or injury of the chest area.

By taking these proactive measures, you can help minimize your risk of developing costochondritis and ensure a more comfortable and active lifestyle.

Conclusion: Embracing a Comprehensive Approach to Costochondritis

Costochondritis may be a common and often misunderstood condition, but with the right understanding and management strategies, it can be effectively addressed. By recognizing the symptoms, identifying the underlying causes, and employing appropriate treatment methods, individuals affected by costochondritis can find relief and regain their quality of life. Remember, if the pain persists or worsens, it’s crucial to consult with a healthcare provider to ensure that there are no other underlying medical conditions that require further attention.

Inflammatory conditions of the eye associated with rheumatic diseases

  • Rothova A, Suttorp-van Schulten MS, Frits Treffers W, et al.:Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 1996, 80:332–336.

    Article 
    PubMed 
    CAS 

    Google Scholar 

  • Ellwein LB, Fletcher A, Negrel AD, Thulasiraj RD: Quality of life assessment in blindness prevention interventions. Int Ophthalmol Clin 1994, 18:263–268.

    Google Scholar 

  • Vedot E, Barth E, Billet P: Epidemiology of uveitis: preliminary results of a prospective study in Savoy. In Uveitis Update. Edited by Sarri KM. Amsterdam: Elsevier; 1984:13.

    Google Scholar 

  • Foster CS, O’Brien JM: Anterior uveitis. In Principles and Practice of Ophthalmology. Edited by Albert and Jakobiec. Philadelphia: WB Saunders; 1999:1198. This chapter describes disease entities, many of them rheumatologic, that lead to anterior uveitis.

    Google Scholar 

  • Harper SL, Foster CS: The ocular manifestations of rheumatoid disease. Int Ophthalmol Clin 1998, 38:1–19.

    Article 
    PubMed 
    CAS 

    Google Scholar 

  • Mody GM, Hill JC, Meyers OL: Keratoconjunctivitis sicca in rheumatoid arthritis. Clin Rheumatol 1988, 7:237.

    Article 
    PubMed 
    CAS 

    Google Scholar 

  • Alspaugh MA, Talal N, Tan EM: Differentiation and characterization of autoantibodies and their antigens in Sjogren’s syndrome. Arthritis Rheum 1976, 19:216–222.

    Article 
    PubMed 
    CAS 

    Google Scholar 

  • Moutsopoulos HM, Mann DL: Genetic differences between primary and secondary sicca syndrome. N Engl J Med 1979, 301:761.

    Article 
    PubMed 
    CAS 

    Google Scholar 

  • Williamson J: Incidence of eye disease in cases of connective tissue disease. Trans Ophthal Soc UK 1974, 94:742.

    PubMed 
    CAS 

    Google Scholar 

  • Sainz de la Maza M, Foster CS, Jabbur NS: Scleritis associated with rheumatoid arthritis and with other systemic immunemediated diseases. Ophthalmology 1994, 101:1281.

    Google Scholar 

  • Watson PG, Hayreh SS: Scleritis and episcleritis. Br J Ophthalmol 1976, 60:163.

    Article 
    PubMed 
    CAS 

    Google Scholar 

  • Tauber J, Sainz de la Maza M: An analysis of therapeutic decision making regarding immunosuppressive chemotherapy for peripheral ulcerative keratitis. Cornea 1990, 9:66.

    Article 
    PubMed 
    CAS 

    Google Scholar 

  • Messmer EM, Foster CS: Destructive corneal and scleral disease associated with rheumatoid arthritis. Cornea 1995, 14:408.

    Article 
    PubMed 
    CAS 

    Google Scholar 

  • Jabs DA, Rosenbaum JT, Foster CS, et al.
    Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 2000, 130:492. This paper provides an expert panel of physician recommendations of immunosuppressive drugs for treatment of patients with ocular inflammatory disorders. The side-effects and complications of corticosteroids support the rationale for immunosuppressive treatment. The treatment regimen with immunosuppressive agents should be individualized and the patients monitored regularly.

    Article 
    PubMed 
    CAS 

    Google Scholar 

  • Cassidy JT, Levinson JE: A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum 1986, 29:274.

    Article 
    PubMed 
    CAS 

    Google Scholar 

  • Chylack LT, Biengang DC: Ocular manifestations of juvenile rheumatoid arthritis. Am J Ophthalmol 1975, 79:1026.

    PubMed 

    Google Scholar 

  • Wolf MD, Lichter PR, Ragsdale CG: Prognostic factors in the uveitis of juvenile rheumatoid arthritis. Ophthalmology 1987, 94:1242.

    PubMed 
    CAS 

    Google Scholar 

  • Rosenberg AM, Oen KG: The relationship between ocular and articular disease activity in children with juvenile rheumatoid arthritis and associated uveitis. Arthritis Rheum 1986, 29:797.

    Article 
    PubMed 
    CAS 

    Google Scholar 

  • Southwood TR, Ryder CA: Ophthalmological screening in juvenile arthritis: should the frequency of screening be based on the risk of developing chronic iridocyclitis? Br J Rheumatol 1992, 31:633.

    Article 
    PubMed 
    CAS 

    Google Scholar 

  • Kanski JJ: Anterior uveitis in juvenile rheumatoid arthritis. Arch Ophthalmol 1977, 95:1794.

    PubMed 
    CAS 

    Google Scholar 

  • “>

    O’Brien JM, Albert DM: Therapeutic approaches for ophthalmic problems in juvenile rheumatoid arthritis. Rheum Dis Clin North Am 1989, 15:413.

    PubMed 

    Google Scholar 

  • Foster CS, Barrett F: Cataract development and cataract surgery in patients with juvenile rheumatoid arthritisassociated iridocyclitis. Ophthalmology 1993, 100:809–817.

    PubMed 
    CAS 

    Google Scholar 

  • Brewerton DA, Caffrey M: Acute anterior uveitis and HLA27. Lancet 1973, 2:994.

    Article 

    Google Scholar 

  • Linssen A: B27+ disease versus B27-disease. Scand J Rheumatol 1990, 87:111.

    Article 
    CAS 

    Google Scholar 

  • Nusenblatt RE, Whitcup SM, Palestine AG: Uveitis Fundaments and Clinical Practice. St Louis: Mosby; 1996:270–273.

    Google Scholar 

  • Spaeth GL: Corneal staining in systemic lupus erythematosus. N Engl J Med 1967, 276:1168.

    Article 
    PubMed 
    CAS 

    Google Scholar 

  • Gold DH, Morris DH, Henkind P: Ocular findings in systemic lupus erythematosus. Br J Ophthalmol 1972, 56:800.

    Article 
    PubMed 
    CAS 

    Google Scholar 

  • Stafford-Brady FJ: Lupus retinopathy: patterns, associations, and prognosis. Arthritis Rheum 1988, 31:1105.

    Article 
    PubMed 
    CAS 

    Google Scholar 

  • Foster CS: Systemic lupus erythematosus. In Principles and Practice of Ophthalmology. Edited by Albert and Jakobiec. Philadelphia: WB Saunders; 1999:4563. This chapter summarizes clinical findings of systemic lupus erythematosus and its ophthalmic findings in detail.

    Google Scholar 

  • Kearns TP: Collagen and rheumatic diseases: ophthalmic aspects. In The Eye and Systemic Disease. Edited by Masolf FA. St Louis: Mosby; 1975:105.

    Google Scholar 

  • Rynes RI, Mika P, Bartholomew LE: Development of giant cell (temporal) arteritis in a patient “adequately” treated for polymyalgia rheumatica. Ann Rheum Dis 1977, 36:88.

    Article 
    PubMed 
    CAS 

    Google Scholar 

  • Hollenhorst RW, Rown JR, Wagener HP, Shick RM: Neurologic aspects of temporal. Neurology 1960, 10:490.

    PubMed 
    CAS 

    Google Scholar 

  • “>

    Afshari NA, Afshari MA, Lessell S: Temporal arteritis. Int Ophthalmol Clin 2001, 41:151–158. This paper summarizes temporal arteritis and its ocular findings.

    Article 
    PubMed 
    CAS 

    Google Scholar 

  • Huston KA, Hunder FF, Lie JT, et al.: Temporal arteritis: a 25-year epidemiological, clinical and pathologic study. Ann Intern Med 1978, 8:162.

    Google Scholar 

  • Bullen CL, Liesegang TJ, McDonald TJ, et al.: Ocular complications of Wegener’s granulomatosis. Ophthalmology 1983, 90:279.

    PubMed 
    CAS 

    Google Scholar 

  • Fauci AS, Haynes BF, Katz P, Wolff SM: Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983, 98:76–85.

    PubMed 
    CAS 

    Google Scholar 

  • Wise GN: Ocular periarteritis nodosa. Arch Ophthalmol 1952, 47:1–11.

    Google Scholar 

  • Moore GJ, Sevel D: Corneo-scleral ulceration in periarteritis nodosa. Br J Ophthalmol 1966, 50:651–655.

    Article 
    PubMed 
    CAS 

    Google Scholar 

  • Purcell JJ, Birkenkamp R, Tsai CC: Conjunctival lesions in periarteritis nodosa. Arch Ophthalmol 1984, 102:736.

    PubMed 

    Google Scholar 

  • Dolan DL, Lemmon GB Jr, Teitelbaum SL: Relapsing polychondritis chondritis. Am J Med 1966, 41:285–299.

    Article 
    PubMed 
    CAS 

    Google Scholar 

  • “>

    Zeuner M, Straub RH, Rauh G, et al.: Relapsing polychondritis: clinical and immunogenetic analysis of 62 patients. J Rheumatol 1997, 24:96–101.

    PubMed 
    CAS 

    Google Scholar 

  • Isaak BL, Liesegang TJ, Michet CJ Jr: Ocular and systemic findings in relapsing polychondritis. Ophthalmology 1986, 93:681–689.

    PubMed 
    CAS 

    Google Scholar 

  • Messmer EM, Foster CS: Vasculitic peripheral ulcerative keratitis. Surv Ophthalmol 1999, 43:379–396. This paper describes in detail the clinical findings and management of vasculitic conditions such as rheumatoid arthritis, systemic lupus erythematosus, WG, RP, and PAN associated with peripheral ulcerative keratitis, as PUK may be the first sign of systemic necrotizing vasculitis.

    Article 
    PubMed 
    CAS 

    Google Scholar 

  • “>

    Bhisitkul RB, Foster CS: Diagnosis and ophthalmological features of BehÇet’s disease. Int Ophthalmol Clin 1996, 36:127.

    Article 
    PubMed 
    CAS 

    Google Scholar 

  • Costochondritis: Causes, symptoms, and treatment

    Costochondritis is an inflammation of the cartilage connecting the ribs to the breastbone. It can cause a stabbing, burning, or aching pain in the chest wall, especially around the second to fifth ribs. Coughing and a blow to the chest are among the causes.

    The ribs are connected to the breastbone by tough, protective tissue called cartilage. When this cartilage becomes inflamed, the condition is known as costochondritis or chest wall pain.

    While this condition is usually temporary, it can be alarming, as the pain can become so significant it mimics a heart attack.

    Doctors may also refer to costochondritis as costosternal syndrome or costosternal chondrodynia. The condition will usually resolve on its own with home treatments.

    Fast facts on costochondritis

    • In many cases, doctors do not know what causes costochondritis.
    • Pain in the chest and breastbone area is the chief symptom of costochondritis.
    • The pain may be so severe that the person feels they are having a heart attack.
    • Treatment includes anti-inflammatory medications.

    Was this helpful?

    Share on PinterestUsually costochondritis will resolve itself with home treatment, and is a temporary condition.

    Though causes are often unknown, in some instances, the condition can be the result of one or more of the following:

    • history of an illness that causes a lot of coughing
    • heavy lifting or strenuous exercise, involving the upper extremities and chest wall
    • carrying heavy bags, such as a heavy backpack on one side or the other
    • having large breasts
    • history of chest injuries or chest infections
    • undergoing surgery that affects the chest wall, such as cardiac bypass

    Doctors call costochondritis that has no known causes idiopathic costochondritis.

    Chest discomfort and pain may be stabbing, burning, or aching in nature. The ribs most affected are the second to fifth ones.

    The condition most commonly affects those older than age 40, according to an article in the journal American Family Physician. An estimated 13-36 percent of those who seek emergency medical attention for chest pain are experiencing costochondritis.

    The following activities usually worsened the pain associated with costochondritis:

    • significant amount of coughing
    • strenuous exercise
    • physical activity using the upper arms, such as lifting boxes

    The pain associated with costochondritis usually occurs on the left side of the body but can affect both sides.

    Tietze syndrome

    There is a variation of costochondritis called Tietze syndrome. This condition causes pain associated with costochondritis, as well as swelling of the rib cartilage.

    The swelling of Tietze syndrome affects at least one of the upper four ribs, usually the second or third ribs. While the pain associated with costochondritis may subside with time, some people with Tietze syndrome will still experience the swelling.

    Although doctors have not defined how prevalent this condition is, they do consider it to be a rare disorder. Other than pain and discomfort, it does not cause any long-term harmful effects.

    Share on PinterestThe symptoms of costochondritis can be worsened by certain activities, such as lifting heavy objects, or strenuous coughing.

    Doctors usually treat costochondritis conservatively. Resting and avoiding strenuous exercise that affects the chest wall can help. So can over-the-counter pain relievers, such as ibuprofen or acetaminophen.

    Children under age 18 should not take aspirin due to the increased risk for Reye’s syndrome.

    In rare instances, a doctor may recommend injections of lidocaine or corticosteroids to reduce pain and inflammation. Other treatments that may help to relieve chest pain include:

    • Applying moist heat by way of warm compresses.
    • Taking cough suppressants to ease coughing and reduce pressure to the cartilage.
    • Physical therapy to ease tension in the chest wall.

    If these treatments do not reduce a person’s incidence of costochondritis, they should seek a follow-up with their doctor.

    If a person is having chest pain, they should not try to determine for themselves if it is a heart-related issue or costochondritis. Instead, they should seek immediate medical attention.

    If a younger person who is not at risk of heart attack experiences these symptoms, they should seek emergency attention if their chest pain is sharp and does not improve with rest.

    If someone has gone to a doctor for their symptoms and has been diagnosed with costochondritis, there are still some instances when a person should seek immediate medical attention again. These include:

    • feeling faint, dizzy, or lightheaded
    • feeling as if the heart is beating irregularly or too fast
    • pain that worsens over time or cannot be relieved by pain medicine
    • having a shortness of breath
    • a fever that is higher than 100. 4 °F in an adult
    • coughing up dark-colored sputum or blood

    If the chest pain is radiating to the arms, neck, shoulder, jaw, or back, a person should seek immediate medical attention.

    Share on PinterestSome conditions may seem similar to costochondritis, including an injured shoulder or neck, or arthritis of the surrounding joints.

    Doctors often diagnose costochondritis by ruling out other potential causes of the chest pain and discomfort connected with the condition. For example, if a person is older than 35, a doctor may first want to rule out coronary artery disease (CAD), as a potential cause.

    Individuals who are at risk of CAD, such as those with a family history, those who are obese, or those with a history of smoking, should usually have an electrocardiogram (ECG or EKG) and chest X-ray to check for CAD.

    Other medical conditions that may closely resemble costochondritis include:

    • arthritis of the shoulder or nearby joints
    • chest wall infections or cancer
    • fibromyalgia, a condition that causes nerve pain
    • slipping rib syndrome, when there is too much mobility in the cartilage supporting the ribs
    • injuries to the shoulder or neck that causes pain to refer or travel to the chest wall

    A physical examination to detect tenderness of the cartilage to the touch may also be performed. If a person is having a heart attack or has another type of heart condition, the cartilage in the chest is not usually sensitive to the touch.

    A doctor will also listen to the heart and lungs, as well as examine the skin for any signs of infection. An X-ray or other imaging studies will not show signs of costochondritis.

    Doctors can usually diagnose a child, adolescent, or young adult by asking questions about their medical history and by conducting a physical exam. The doctor will often check for tenderness in the chest cartilage, as part of this.

    According to American Family Physician, costochondritis can last anywhere from a few weeks to months. It may also recur if it has been caused by physical exercise or strain.

    The condition does not usually last longer than one year. However, adolescents with costochondritis can sometimes have a longer period of symptoms.

    90,000 legendary commandant: Life and death of Fidel Castro

    https://ria.ru/20210813/kastro-7455572100. html

    Legendary Castille Castro

    Legendary Kastel – RIA Novosti, RIA Novosti, RIA Novosti, RIA Novosti 08/13/2021

    The legendary Comandante: the life and death of Fidel Castro

    Cuban revolutionary Fidel Castro would have turned 95 on August 13. Five years ago, the world saw off the legendary Comandante on his last journey.

    2021-08-13T07:47

    2021-08-13T07:47

    2021-08-13T07:47

    video

    cube

    90 002 fidel castro

    /html/head/meta[@name=’ og:title’]/@content

    /html/head/meta[@name=’og:description’]/@content

    https://cdnn21.img.ria.ru/images/07e5/08/0d /1745572059_0:0:640:360_1920x0_80_0_0_1f8ad23fe2f3128adf72e6fd898a8dd2.jpg

    He died a natural death at an advanced age despite numerous attempts on his life. According to the leadership of Cuba’s counterintelligence service, there were more than 600 attempts to assassinate Castro. They tried to shoot the revolutionary, poison him with toxic substances and poisons.

    cubes

    RIA Novosti

    1

    5

    4.7

    96

    [email protected]

    7 4 95 645-6601

    FSUE MIA Rossiya Segodnya

    https://xn –c1acbl2abdlkab1og.xn--p1ai/awards/

    2021

    RIA Novosti

    1

    5

    4.7

    96

    [email protected]

    7 495 645-6601

    FSUE MIA Russia Today

    https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/

    News

    ru-RU

    https://ria.ru/docs/about/copyright.html

    https://xn--c1acbl2abdlkab1og.xn--p1ai/

    RIA Novosti

    1

    5

    4.7

    96

    [email protected]

    7 495 645-6601

    Rossiya Segodnya

    https://xn--c1acbl 2abdlkab1og.xn--p1ai/awards/

    The legendary Comandante: the life and death of Fidel Castro

    Cuban revolutionary Fidel Castro would have turned 9 on August 135 years. Five years ago, the world saw off the legendary Comandante on his last journey. He died a natural death at an advanced age despite numerous attempts on his life. According to the leadership of Cuba’s counterintelligence service, there were more than 600 attempts to assassinate Castro. They tried to shoot the revolutionary, poison him with toxic substances and poisons.

    2021-08-13T07:47

    true

    PT2M13S

    1920

    1080

    true

    1 920

    1440

    true

    1920

    1920

    true

    RIA Novosti

    1

    5

    4.7

    96

    [email protected]

    7 495 645-6601

    Rossiya Segodnya

    900 02 https://xn--c1acbl2abdlkab1og.xn--p1ai/awards /

    RIA Novosti

    1

    5

    4.7

    96

    [email protected]

    7 495 645-6601

    Rossiya Segodnya 90 003

    https://xn--c1acbl2abdlkab1og.xn--p1ai /awards/

    video, cuba, Fidel Castro, video

    Video, Cuba, Fidel Castro

    The legendary Comandante: the life and death of Fidel Castro

    Cuban revolutionary Fidel Castro would have turned 95 on August 13.